Peter Lommer Kristensen

1 ta ish

Novo Nordisk (Denmark)

1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

   Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen +12

   MaqolaOAOchiq kirish20164 iqtibos

   ABIABI:AkademIndex/2026.other.057706